Join
Live feed
·
PRReleasevia Quantisnow
Orchestra BioMed Holdings Inc. logo

Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy

ByQuantisnow·Wall Street's wire, on your screen.
OBIO· Orchestra BioMed Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OBIO (Orchestra BioMed Holdings Inc.) and more on Quantisnow.